Bioethics, Ltd.
BOTH
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.36K
Close$
Share Statistics
| Market cap | $18,360.00 |
|---|---|
| Enterprise Value | $423,478.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | -6.53 |
| Outstanding Shares | 3,335,194 |
Return
| Return on Equity | 19.00% |
|---|---|
| Return on Assets | -1206.73% |
| Return on Invested Capital | 13.19% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.04 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.45 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -0.45 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bioethics, Ltd.
1 employees
CEO: Mark A. Scharmann Established in 1990 and located in Ogden, Utah, Bioethics, Ltd. is not currently involved in substantial business activities. Instead, the company plans to explore, assess, and, if appropriate, acquire a stake in a new commercial enterprise.